Login with your work email address to view charts. No credit card required.
| Art Unit: | 1636 — Chemistry: molecular biology and microbiology |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 514 — Drug, bio-affecting and body treating compositions 504 — Plant protecting and regulating compositions 435 — Chemistry: molecular biology and microbiology 536 — Organic compounds -- part of the class 532-570 series 604 — Surgery 132 — Toilet 366 — Agitating 423 — Chemistry of inorganic compounds 264 — Plastic and nonmetallic article shaping or treating: processes |
| Phone: | (571) 270-3502 |
| Email: | abigail.vanhorn@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Org Chem |
| Service: | 19 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 45% over 432 cases |
|---|---|
| Difficulty: | Very Hard |
| Difficulty Percentile: | 84th
|
With Examiner Vanhorn, you have a 45% chance of getting an issued patent by 3 years after the first office action. Examiner Vanhorn is a very hard examiner and in the 84th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Vanhorn, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Vanhorn's grant rate is lower than that of Art Unit 1636 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Vanhorn | 2.3 |
| Art Unit 1636 | 1.9 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.